Grifols

HYPERTET S-D - Cost

Updated as of: July 1st, 2024

HCPCS:

J1670

HCPCS Code Descriptor:

Injection, tetanus immune globulin, human, up to 250 units

Medicare Payment Limit:

The Hypertet S-D Medicare Payment Limit is $564.921.

Average Sale Price:

HYPERTET S-D ASP cost available once logged in.

Medicare Co-Insurance Percentage:

The Hypertet S-D Medicare Co-Insurance percentage is 20%. Hypertet S-D's Medicare Co-Insurance amount is $112.984

APC Code:

The Hypertet S-D APC Code is: 1670

APC Payment Limit:

The APC Payment Limit for HYPERTET S-D is available. Login to view.

Hypertet S-D Cost Information:

HYPERTET S-D, manufactured by Grifols, became effective on January 1, 1997, and is aligned to HCPCS J1670. Historic pricing indicates a gradual increase of a couple percentage points annually. From the end of 2022 through 2024, ASP has increased slightly by over 5%.

ACCESS PRICING AND MORE BY REGISTERING

Hypertet S-D’s wholesale acquisition cost (WAC) information was last updated on:
January 1, 2024
Hypertet S-D’s average wholesale price (AWP) information was last updated on:
January 1, 2024